Interim Condensed Consolidated Financial Statements - Additional Information (Detail) - USD ($) $ in Millions	1 Months Ended	3 Months Ended
	Sep. 30, 2013	Mar. 31, 2016
Condensed Financial Statements, Captions [Line Items]
Additional license and supply agreement renewals term		5 years
License and supply agreement expiration date		May 19, 2020
Juniper Pharma Services [Member]
Condensed Financial Statements, Captions [Line Items]
Assumed obligation under grant arrangement by the entity	$ 3.9
Juniper Pharma Services [Member] | Regional Growth Fund [Member]
Condensed Financial Statements, Captions [Line Items]
Assumed obligation under grant arrangement by the entity		$ 2.5
Merck KGaA [Member]
Condensed Financial Statements, Captions [Line Items]
Revenue recognition, recorded revenue cost plus percentage		20.00%
Minimum [Member] | Merck KGaA [Member]
Condensed Financial Statements, Captions [Line Items]
Revenue recognition, recorded revenue cost plus percentage		20.00%